000			02286 a2200673 4500
005			20250515204157.0
264		0	_c20100309
008			201003s 0 0 eng d
022			_a1538-7445
024	7		_a10.1158/0008-5472.CAN-09-2762 _2doi
040			_aNLM _beng _cNLM
100	1		_aGalanis, Evanthia
245	0	0	_aPhase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. _h[electronic resource]
260			_bCancer research _cFeb 2010
300			_a875-82 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAbdominal Pain _xetiology
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnimals
650	0	4	_aCarcinoembryonic Antigen _xgenetics
650	0	4	_aChlorocebus aethiops
650	0	4	_aFatigue _xetiology
650	0	4	_aFemale
650	0	4	_aFever _xetiology
650	0	4	_aHumans
650	0	4	_aInjections, Intraperitoneal
650	0	4	_aMeasles virus _xgenetics
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local
650	0	4	_aOncolytic Virotherapy _xadverse effects
650	0	4	_aOncolytic Viruses _xgenetics
650	0	4	_aOvarian Neoplasms _xpathology
650	0	4	_aRecombinant Fusion Proteins _xadministration & dosage
650	0	4	_aTreatment Outcome
650	0	4	_aVero Cells
700	1		_aHartmann, Lynn C
700	1		_aCliby, William A
700	1		_aLong, Harry J
700	1		_aPeethambaram, Prema P
700	1		_aBarrette, Brigitte A
700	1		_aKaur, Judith S
700	1		_aHaluska, Paul J
700	1		_aAderca, Ileana
700	1		_aZollman, Paula J
700	1		_aSloan, Jeff A
700	1		_aKeeney, Gary
700	1		_aAtherton, Pamela J
700	1		_aPodratz, Karl C
700	1		_aDowdy, Sean C
700	1		_aStanhope, C Robert
700	1		_aWilson, Timothy O
700	1		_aFederspiel, Mark J
700	1		_aPeng, Kah-Whye
700	1		_aRussell, Stephen J
773	0		_tCancer research _gvol. 70 _gno. 3 _gp. 875-82
856	4	0	_uhttps://doi.org/10.1158/0008-5472.CAN-09-2762 _zAvailable from publisher's website
999			_c19479675 _d19479675